Understanding how SARS-CoV-2 affects people with HIV
Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection
['FUNDING_R01'] · UNIVERSITY OF WASHINGTON · NIH-10914834
This study is looking at how COVID-19 affects people with weakened immune systems from HIV, to understand why they might get sicker and how the virus changes in their bodies, so we can find better ways to help them stay healthy.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10914834 on ClinicalTrials.gov |
What this research studies
This research investigates how SARS-CoV-2, the virus that causes COVID-19, behaves in individuals who are immunocompromised due to HIV infection. It focuses on the mechanisms that lead to severe COVID-19 outcomes in these patients, including prolonged viral infection and the potential for more dangerous virus variants to emerge. By examining the immune responses and the role of the microbiome in both lung and gastrointestinal health, the study aims to uncover critical factors that contribute to severe disease in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are at risk for severe COVID-19 outcomes.
Not a fit: Patients who are not living with HIV or who do not have compromised immune systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for COVID-19 in individuals living with HIV.
How similar studies have performed: Other research has shown that understanding viral interactions in immunocompromised patients can lead to significant advancements in treatment, suggesting this approach has potential for success.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: O'CONNOR, MEGAN A — UNIVERSITY OF WASHINGTON
- Study coordinator: O'CONNOR, MEGAN A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.